Anders Boysen

4 active roles at 3 companies

Active roles: 4Executive board 3, Owner 1
Registered owner now: 1 company5% or more, as CVR registers owners
Founder (Stifter): 1 company
First role registered: 2017

Active Roles

Boysen Bio ApS

CVR 38655590Private limited companyIkke-finansielle holdingselskaber

Owner, 100% of capital and votes, since 21 May 2017, Executive board since 21 May 2017, Founded 21 May 2017

GlycoPharma Holding ApS

CVR 39691558Private limited companyIkke-finansielle holdingselskaber

Executive board since 28 Jun 2018

GlyProVac ApS

CVR 39724758Private limited companyFremstilling af farmaceutiske præparater4 employees (Aug 2026)

Executive board since 3 Jul 2018, Board of directors 3 Jul 2018 to 1 Mar 2022

Network

Roles Over Time

Boysen Bio ApS: Owner, 21 May 2017 to today; Executive board, 21 May 2017 to today.
GlycoPharma Holding ApS: Executive board, 28 Jun 2018 to today.
GlyProVac ApS: Executive board, 3 Jul 2018 to today; Board of directors, 3 Jul 2018 to 1 Mar 2022.

21 May 2017 to 4 Nov 2026.

Executive board (Direktion)Board of directors (Bestyrelse)Other rolesEach bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Dandex in Your Own Tools

Dandex is Danish company data. Connect it once and ask about Anders Boysen, or anyone in the Danish registry, from your assistant, the API or the command line. Answers come from the current record: every registered role, the people around each company, and each company's owners and financials.

Set Up Dandex

Compiled by Dandex from the Central Business Register (CVR), Erhvervsstyrelsen.

Active Roles

Boysen Bio ApS

CVR 38655590Private limited companyIkke-finansielle holdingselskaber

Owner, 100% of capital and votes, since 21 May 2017, Executive board since 21 May 2017, Founded 21 May 2017

GlycoPharma Holding ApS

CVR 39691558Private limited companyIkke-finansielle holdingselskaber

Executive board since 28 Jun 2018

GlyProVac ApS

CVR 39724758Private limited companyFremstilling af farmaceutiske præparater4 employees (Aug 2026)

Executive board since 3 Jul 2018, Board of directors 3 Jul 2018 to 1 Mar 2022

Network

CompanyPersonAt two or more of their companiesThicker lines are ownershipSource: CVR, read 4 Nov 2026. People and companies are drawn when they hold a current role in, or own 5% or more of, two or more of Anders Boysen's current companies. Their other companies are not followed.

The Network as a List

Their companies that own another of theirs

Boysen Bio ApS owns 33.3% to under 50% of capital and votes of GlycoPharma Holding ApS
GlycoPharma Holding ApS owns 33.3% to under 50% of capital and votes of GlyProVac ApS

Roles Over Time

Boysen Bio ApS: Owner, 21 May 2017 to today; Executive board, 21 May 2017 to today.
GlycoPharma Holding ApS: Executive board, 28 Jun 2018 to today.
GlyProVac ApS: Executive board, 3 Jul 2018 to today; Board of directors, 3 Jul 2018 to 1 Mar 2022.

21 May 2017 to 4 Nov 2026.

Executive board (Direktion)Board of directors (Bestyrelse)Other rolesEach bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Dandex in Your Own Tools

Set Up Dandex